You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

List of Excipients in API ATORVASTATIN CALCIUM


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ATORVASTATIN CALCIUM

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Parke-Davis Div of Pfizer Inc LIPITOR atorvastatin calcium 0071-0155 CALCIUM CARBONATE
Parke-Davis Div of Pfizer Inc LIPITOR atorvastatin calcium 0071-0155 CANDELILLA WAX
Parke-Davis Div of Pfizer Inc LIPITOR atorvastatin calcium 0071-0155 CELLULOSE, MICROCRYSTALLINE
Parke-Davis Div of Pfizer Inc LIPITOR atorvastatin calcium 0071-0155 CROSCARMELLOSE SODIUM
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Sign Up

Excipients in ANDA-approved (generic) drugs containing ATORVASTATIN CALCIUM

Company Ingredient NDC Excipient
Teva Pharmaceuticals USA Inc atorvastatin calcium 0093-5056 CALCIUM CARBONATE
Teva Pharmaceuticals USA Inc atorvastatin calcium 0093-5056 CELLULOSE, MICROCRYSTALLINE
Teva Pharmaceuticals USA Inc atorvastatin calcium 0093-5056 CROSCARMELLOSE SODIUM
Teva Pharmaceuticals USA Inc atorvastatin calcium 0093-5056 HYDROXYPROPYL CELLULOSE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for ATORVASTATIN CALCIUM

Excipient focus: ANHYDROUS LACTOSE

Excipient focus: ARGININE

Excipient focus: CALCIUM ACETATE

Excipient focus: CALCIUM CARBONATE

Excipient focus: CANDELILLA WAX

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: COLLOIDAL SILICON DIOXIDE

Excipient focus: COPOVIDONE

Excipient focus: COPOVIDONE K25-31

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: DIMETHICONE

Excipient focus: DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

ATORVASTATIN CALCIUM drug variants containing DIMETHYLAMINOETHYL METHACRYLATE - BUTYL METHACRYLATE - METHYL METHACRYLATE COPOLYMER

Company Ingredient NDC
NCS HealthCare of KY Inc dba Vangard Labs atorvastatin calcium 0615-7769
NCS HealthCare of KY Inc dba Vangard Labs atorvastatin calcium 0615-7772
PD-Rx Pharmaceuticals Inc atorvastatin calcium 43063-487
Aphena Pharma Solutions - Tennessee LLC atorvastatin calcium 43353-280
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: EGG PHOSPHOLIPIDS

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONOCAPRYLOCAPRATE

Excipient focus: HYDROXYPROPYL CELLULOSE

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: LECITHIN, SOYBEAN

Excipient focus: MAGNESIUM ALUMINOMETASILICATE TYPE I-A

Excipient focus: MAGNESIUM ALUMINOMETASILICATE TYPE IA

Excipient focus: MAGNESIUM STEARATE

Excipient focus: MALTODEXTRIN

Excipient focus: MANNITOL

Excipient focus: METHYL ALCOHOL

Excipient focus: METHYLCELLULOSE

Excipient focus: METHYLENE CHLORIDE

Excipient focus: MICROCRYSTALLINE CELLULOSE

Excipient focus: MICROCRYSTALLINE CELLULOSE 101

Excipient focus: MICROCRYSTALLINE CELLULOSE 102

Excipient focus: MINERAL OIL

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 3350

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 65

Excipient focus: POLYSORBATE 80

Excipient focus: POLYVINYL ALCOHOL

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM BICARBONATE

Excipient focus: SODIUM CARBONATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SODIUM STEARYL FUMARATE

Excipient focus: STARCH, CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TROMETHAMINE

Excipient focus: WATER

Excipient focus: XANTHAN GUM

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group